Alopecia Areata Induced After DRESS Syndrome With Rapid Resolution

    January 2023 in “ Surgical & Cosmetic Dermatology ”
    Maria Fernanda Reis Gavazzoni Dias, Nadia El-Kadi, Ludmila Auzier Bentes Novais, Enoï Aparecida Guedes Vilar, Paulo R. B. Fontinha, Luisa V. Aarão Reis, Justyna Sicińska, Chloe Ekelem
    TLDR The patient quickly recovered from hair loss caused by DRESS syndrome using topical minoxidil.
    A 17-year-old woman experienced severe anagen effluvium (AE), a hair growth disorder, following drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. This condition, commonly caused by alopecia areata (AA), typically persists due to its autoimmune nature. However, in this case, the patient achieved a full and rapid recovery within two months using topical minoxidil, highlighting the potential for quick resolution of AE induced by DRESS syndrome.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community The amazing fast pace of PP405.

      in Chat  322 upvotes 1 month ago
      PP405 is a new hair loss treatment advancing quickly in trials, generating excitement and skepticism about its effectiveness and marketing claims. Some see it as a potential alternative to minoxidil and finasteride, but concerns about long-term effects and the need for DHT blockers persist.

      community AGA evaluation and first steps - BEGINNER MEGAPOST

      in Chat  79 upvotes 1 year ago
      The conversation discusses androgenic alopecia (AGA) and its treatments, focusing on finasteride, minoxidil, and ketoconazole shampoo. Finasteride is recommended as essential for preventing further hair loss.

      community My scalp punch biopsy results🤔?

      in Female  8 upvotes 2 years ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Related Research

    1 / 1 results